Quercetin facilitates cell death and chemosensitivity through RAGE/PI3K/AKT/mTOR axis in human pancreatic cancer cells

被引:129
|
作者
Lan, Chieh-Yu [1 ]
Chen, Sheng-Yi [1 ]
Kuo, Chia-Wen [1 ]
Lu, Chi-Cheng [2 ]
Yen, Gow-Chin [1 ]
机构
[1] Natl Chung Hsing Univ, Dept Food Sci & Biotechnol, 145 Xingda Rd, Taichung 40227, Taiwan
[2] Natl Taiwan Univ Sport, Dept Sport Performance, 16 Sec 1,Shuang Shih Rd, Taichung 40404, Taiwan
关键词
Autophagy; Gemcitabine resistance; Pancreatic cancer; Quercetin; RAGE; RAGE; APOPTOSIS; GEMCITABINE; EXPRESSION; AUTOPHAGY; FLAVONOIDS; RESISTANCE; RECEPTOR; GROWTH;
D O I
10.1016/j.jfda.2019.07.001
中图分类号
TS2 [食品工业];
学科分类号
0832 ;
摘要
The triggering of gemcitabine (GEM) drug resistance in pancreatic cancer by the receptor for advanced glycation end products (RAGE) has been demonstrated. Hence, finding a safe and effective adjuvant for preventing pancreatic cancer progression is imperative. Quercetin is a flavonoid that is abundant in apples, grapes, red raspberry, and onions and has been reported to inhibit RAGE. This research aimed to investigate the mechanisms of quercetin in regulating cell death and enhancing drug effects through RAGE reduction, especially in GEM-resistant pancreatic cancer cells. Our results showed that silencing RAGE expression by RAGE-specific siRNA transfection significantly increased cell death by apoptosis, autophagy and GEM-induced cytotoxicity by suppressing the PI3K/AKT/mTOR axis in MIA Paca-2 and MIA Paca-2 (GEMR) cells (GEM-resistant cells). Notably, quercetin showed a dramatic effect similar to RAGE silencing that effectively attenuated RAGE expression to facilitate cell cycle arrest, autophagy, apoptosis, and GEM chemosensitivity in MIA Paca-2 GEMR cells, suggesting that an additional reaction occurred under combined quercetin and GEM treatment. In conclusion, the results demonstrated that the molecular mechanisms of quercetin in regulating apoptosis and autophagy-related pathways and increasing GEM chemosensitivity in pancreatic cancer cells involved inhibition of RAGE expression. Copyright (C) 2019, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan LLC.
引用
收藏
页码:887 / 896
页数:10
相关论文
共 50 条
  • [11] Sennoside A induces autophagic death of prostate cancer via inactivation of PI3K/AKT/mTOR axis
    Shaoyi Qiao
    Wuhe Zhang
    Yao Jiang
    Yansheng Su
    Journal of Molecular Histology, 2023, 54 : 645 - 654
  • [12] Inhibition of the PI3K/AKT/mTOR pathway in pancreatic cancer: is it a worthwhile endeavor?
    Ouissam, Al Jarroudi
    Hind, Chibani
    Aziz, Brahmi Sami
    Said, Afqir
    THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY, 2024, 16
  • [13] Regulation of pancreatic cancer cells by suppressing KIN17 through the PI3K/AKT/mTOR signaling pathway
    Li, Qiuyan
    Yang, Yuxia
    Lin, Xiaocong
    Chu, Lok Ting
    Chen, Helian
    Chen, Linsong
    Tang, Jinjing
    Zeng, Tao
    ONCOLOGY REPORTS, 2025, 53 (02)
  • [14] Roles of PI3K/AKT/mTOR Axis in Arteriovenous Fistula
    Ratti, Stefano
    Mauro, Raffaella
    Rocchi, Cristina
    Mongiorgi, Sara
    Ramazzotti, Giulia
    Gargiulo, Mauro
    Manzoli, Lucia
    Cocco, Lucio
    Fiume, Roberta
    BIOMOLECULES, 2022, 12 (03)
  • [15] PI3K/AKT/mTOR Signaling and Differentiation of Human iPS Cells
    Cross, Alan
    Jaishankar, Amritha
    Brandon, Nicholas
    Wesolowski, Steve
    Burli, Roland
    Hoeppner, Dan
    Kim, Suel-Kee
    Seo, Seungmae
    Shin, Joo Heon
    Colantuoni, Carlo
    Chenoweth, Josh
    Weinberger, Daniel
    McKay, Ron
    NEUROPSYCHOPHARMACOLOGY, 2016, 41 : S541 - S542
  • [16] Plumbagin induces apoptotic and autophagic cell death through inhibition of the PI3K/Akt/mTOR pathway in human non-small cell lung cancer cells
    Li, Yan-Cong
    He, Shu-Ming
    He, Zhi-Xu
    Li, Minghua
    Yang, Yinxue
    Pang, Jian-Xin
    Zhang, Xueji
    Chow, Kevin
    Zhou, Qingyu
    Duan, Wei
    Zhou, Zhi-Wei
    Yang, Tianxin
    Huang, Gui-Hua
    Liu, Aibing
    Qiu, Jia-Xuan
    Liu, Jun-Ping
    Zhou, Shu-Feng
    CANCER LETTERS, 2014, 344 (02) : 239 - 259
  • [17] PI3K/Akt/mTOR signaling pathway in cancer stem cells
    Fath, Mohsen Karami
    Ebrahimi, Menooa
    Nourbakhsh, Ehsan
    Hazara, Ahmad Zia
    Mirzaei, Ali
    Shafieyari, Saba
    Salehi, Azadeh
    Hoseinzadeh, Mahsa
    Payandeh, Zahra
    Barati, Ghasem
    PATHOLOGY RESEARCH AND PRACTICE, 2022, 237
  • [18] Activation of PI3K/Akt/mTOR Pathway and Dual Inhibitors of PI3K and mTOR in Endometrial Cancer
    Chen, Jiezhong
    Zhao, Kong-Nan
    Li, Rui
    Shao, Renfu
    Chen, Chen
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (26) : 3070 - 3080
  • [19] Deguelin, A PI3K/AKT inhibitor, enhances chemosensitivity of leukaemia cells with an active PI3K/AKT pathway
    Bortul, R
    Tazzari, PL
    Billi, AM
    Tabellini, G
    Mantovani, I
    Cappellini, A
    Grafone, T
    Martinelli, G
    Conte, R
    Martelli, AM
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 (05) : 677 - 686
  • [20] The PI3K/AKT/MTOR signaling pathway: The role of PI3K and AKT inhibitors in breast cancer
    Huemer F.
    Bartsch R.
    Gnant M.
    Current Breast Cancer Reports, 2014, 6 (2) : 59 - 70